Earnings release · DXCM
Dexcom Reports Third Quarter 2026 Financial Results
Dexcom Inc. · Filed · SEC Form 8-K, Item 2.02
Revenue
$1.344 billion
+11% vs a year ago
EPS
—
not detected
Guidance
raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
Why it matters
Revenue rose 11% year on year to $1.344 billion. Management raised its outlook, and guidance changes often matter more to the market than the quarter just reported because they reflect expectations for the periods ahead.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
Revenue
$1.344 billion +11% vs a year ago
…Revenue grew 11% year-over-year to $1.344 billion on a reported basis and 11% year-over-year on…
Guidance
Guidance raised
…“This performance enabled us to again raise our full-year revenue and operating margin guidance and reinforces our confidence in our ability to deliver on the long-term objectives we outlined at Investor Day.”. 2026 Annual Guidance. | Dexcom is raising the midpoint of fiscal year…
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.